13.04.2021 15:21:25
|
Smith+Nephew: Randomized Clinical Trial Shows Benefit Of LEAF Patient Monitoring System
(RTTNews) - Smith+Nephew (SN.L, SNN) said its wireless, wearable LEAF Patient Monitoring System has monitored more than 60,000 patients with over 7 million hours of use. A randomized clinical trial conducted using the LEAF System showed that hospital acquired pressure injury odds were reduced by 73%.
First deployed in healthcare facilities in 2014, the LEAF System was the first FDA-cleared device to monitor patient orientation and activity in bed-bound, chair-bound, and ambulatory patients. The LEAF System helps measure turn frequency, turn angle and tissue recovery time to improve patient repositioning.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Smith & Nephew PLCShs Sponsored American Deposit Receipt Repr 5 Shsmehr Nachrichten
Keine Nachrichten verfügbar. |